Zhi-Dong Jiang
Credentials:
History
- 2014–2017
Residency
UTHealth Houston School of Public Health
- 2010–2014
Medical School
Research
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Nature Medicine · 2018 · 628 citations
The Journal of Infectious Diseases · 2002 · First of 9 authors · Corresponding · 194 citations
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea
Annals of Internal Medicine · 2005 · 172 citations
120 papers
30 papers
25 papers
17 papers
- JM
16 papers
14 papers · 9 as a fellow
12 papers
- JF
9 papers · 7 as a resident
Grants
- 2004–2005
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $6.3K · University of Texas Hlth Sci Ctr Houston
Clinical trials
- 2013–2018
Principal investigator · Completed · Phase 1, Phase 2
The University of Texas Health Science Center, Houston